Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
CaixaBank $2 billion notes offering under $5 billion U.S. MTN program
The offering involved senior non-preferred callable fixed-to-floating-rate notes due 2027 and 2034
Rollins $1.3 billion inaugural secondary offering
The shares are listed on the New York Stock Exchange
Marsh McLennan $1.6 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Natera $250 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
CSG Systems International $425 million convertible senior notes offering
The 3.875% convertible notes are due 2028
Mitsubishi HC Finance America $500 million guaranteed notes offering
We advised Mitsubishi HC Finance America and Mitsubishi HC Capital on the guaranteed senior notes offering
Nippon Life Insurance $930 million subordinated notes offering
We advised Nippon Life on its offering of step-up callable subordinated notes
J. M. Smucker $5.2 billion Hostess Brands acquisition bridge financing
We are advising the arrangers and the agent on the financing
Rapid7 $260 million convertible notes offering and capped call transactions
We advised Rapid7 on the offering
CSX $600 million senior notes offering
We advised CSX on the investment-grade debt offering